Insider Transactions in Q1 2025 at Acadia Pharmaceuticals Inc (ACAD)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
773
-1.41%
|
$14,687
$19.96 P/Share
|
|
Feb 24
2025
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
475
-2.29%
|
$9,025
$19.96 P/Share
|
|
Feb 23
2025
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,353
+2.42%
|
-
|
|
Feb 23
2025
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
840
+3.9%
|
-
|